Holleman, A.

leukemia expression resistance lymphoblastic leukemia drug resistance apoptosi patient childhood lymphoblastic protein caspase children blood procaspase study treatment pieters r opal 1 expression cancer den boer ml level sample group apoptotic outcome activation leukemic pieter b-lineage prednisolone chapter vincristine caspase -3 activation probe leukemic cells l-asparaginase figure janka-schaub ge veerman ajp response t-lineage death analysis table sensitivity subtype van wering pathway prognosis relation daunorubicin agent apoptotic parameters probe sets tel-aml therapy value defect mitochondrial parp inactivation leukemia cells factor protocol gene expression number myeloid leukemia coall j biol chem relling mv gene-expression netherland pui ch cell lines prognostic treatment outcome survival drug-induced drug-induced apoptosis opal 1 result